Federal Register / Vol. 61, No. 130 / Friday, July 5, 1996 / Notices 35229

Antioxidants and/or stabilizers for

polymers (21 CFR 178.2010) to provide

for the expanded safe use of

phosphorous acid, cyclic

neopentanetetrayl bis(2,6-di-tert-butyl4-methylphenyl)ester for use (i) at levels

not to exceed 0.25 percent by weight of

olefin polymers complying with

§ 177.1520 (21 CFR 177.1520) in contact

with foods of types I, II, III, IV–B, VI–

B, and VIII, as described in Table 1, and

under conditions of use B through H

described in Table 2 of § 176.170(c) (21

CFR 176.170(c)) of this chapter, and

with foods of types IV–A, V, VI–A, VI–

C, VII–A, and IX, under conditions of

use C through G, as described in

§ 176.170(c) of this chapter, Tables 1

and 2 respectively; and (ii) at levels not

to exceed 0.10 percent by weight of

either olefin polymers or polypropylene

complying with § 177.1520 which may

be used only in contact with foods of

types IV–A, V, VI–C, VII–A, and IX,

under conditions of use H, as described

in § 176.170(c) of this chapter, Tables 1

and 2 respectively. Asahi Denka Kogyo

K. K. has now withdrawn the petition

without prejudice to a future filing (21

CFR 171.7).

Dated: June 12, 1996.

Alan M. Rulis,

Director, Office of Premarket Approval,

Center for Food Safety and Applied Nutrition.

[FR Doc. 96–17104 Filed 7–3–96; 8:45 am]

BILLING CODE 4160–01–F

[Docket No. 96F–0214]

Ciba-Geigy Corp.; Filing of Food

Additive Petition

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing

that Ciba-Geigy Corp. has filed a

petition proposing that the food additive

regulations be amended to provide for

the safe use of 2,9-dichloro-5,12-

dihydroquinone[2,3-b]acridine-7,14-

dione (C. I. Pigment Red 202) as a

colorant in polymers used in contact

with food.

DATES: Written comments on

petitioner’s environmental assessment

by August 5, 1996.

ADDRESSES: Submit written comments

to the Dockets Management Branch

(HFA–305), Food and Drug

Administration, 12420 Parklawn Dr.,

rm. 1–23, Rockville, MD 20857.

FOR FURTHER INFORMATION CONTACT: Vir

D. Anand, Center for Food Safety and

Applied Nutrition (HFS–216), Food and

Drug Administration, 200 C St. SW.,

Washington, DC 20204, 202–418–3081.

SUPPLEMENTARY INFORMATION: Under the

Federal Food, Drug, and Cosmetic Act

(sec. 409(b)(5) (21 U.S.C. 348(b)(5))),

notice is given that a food additive

petition (FAP 6B4512) has been filed by

Ciba-Geigy Corp., 335 Water St.,

Newport, DE 19804. The petition

proposes to amend the food additive

regulations in § 178.3297 Colorants for

polymers (21 CFR 178.3297) to provide

for the safe use of 2,9-dichloro-5,12-

dihydroquinone[2,3-b]acridine-7,14-

dione (C. I. Pigment Red 202) as a

colorant in polymers used in contact

with food.

The potential environmental impact

of this action is being reviewed. To

encourage public participation

consistent with regulations promulgated

under the National Environmental

Policy Act (40 CFR 1501.4(b)), the

agency is placing the environmental

assessment submitted with the petition

that is the subject of this notice on

display at the Dockets Management

Branch (address above) for public

review and comment. Interested persons

may, on or before (insert date 30 days

after date of publication in the Federal

Register), submit to the Dockets

Management Branch (address above)

written comments. Two copies of any

comments are to be submitted, except

that individuals may submit one copy.

Comments are to be identified with the

docket number found in brackets in the

heading of this document. Received

comments may be seen in the office

above between 9 a.m. and 4 p.m.,

Monday through Friday. FDA will also

place on public display any

amendments to, or comments on, the

petitioner’s environmental assessment

without further announcement in the

Federal Register. If, based on its review,

the agency finds that an environmental

impact statement is not required and

this petition results in a regulation, the

notice of availability of the agency’s

finding of no significant impact and the

evidence supporting that finding will be

published with the regulation in the

Federal Register in accordance with 21

CFR 25.40(c).

Dated: June 20, 1996.

George H. Pauli,

Acting Director, Office of Premarket

Approval, Center for Food Safety and Applied

Nutrition.

[FR Doc. 96–17105 Filed 7–3–96; 8:45 am]

BILLING CODE 4160–01–F

[Docket No. 92C–0179]

Microbio Resources, Inc.; Withdrawal

of a Color Additive Petition

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing the

withdrawal, without prejudice to future

filing, of a color additive petition (CAP

1C0237) proposing that the color

additive regulations be amended to

provide for the safe use of comminuted

Haematococcus pluvialis algae meal as

a color additive in aquaculture feeds.

FOR FURTHER INFORMATION CONTACT:

James C. Wallwork, Center for Food

Safety and Applied Nutrition (HFS–

217), Food and Drug Administration,

200 C St. SW., Washington, DC 20204–

0001, 202–418–3066.

SUPPLEMENTARY INFORMATION: In a notice

published in the Federal Register of

June 18, 1992 (57 FR 27256), FDA

announced that a color additive petition

(CAP 1C0237) had been filed by

Microbio Resources, Inc., 6150 Lusk

Blvd., suite B–105, San Diego, CA

92121. The petition proposed that 21

CFR part 73 of the color additive

regulations be amended to provide for

the safe use of comminuted

Haematococcus pluvialis algae meal as

a color additive in aquaculture feeds.

Microbio Resources, Inc., 18278 Hadden

Hall Ct., San Diego, CA 92128, has now

withdrawn the petition without

prejudice to a future filing (21 CFR

71.6(c)(2)).

Dated: June 20, 1996.

George H. Pauli,

Acting Director, Office of Premarket

Approval, Center for Food Safety and Applied

Nutrition.

[FR Doc. 96–17059 Filed 7–3–96; 8:45 am]

BILLING CODE 4160–01–F

Advisory Committees; Notice of

Meetings

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: This notice announces

forthcoming meetings of public advisory

committees of the Food and Drug

Administration (FDA). This notice also

summarizes the procedures for the

meetings and methods by which

interested persons may participate in

open public hearings before FDA’s

advisory committees.

FDA has established an Advisory

Committee Information Hotline (the